This prestigious honour recognizes suppliers for performances and measurable impact on Lilly’s corporate priorities through the delivery of exemplary quality, speed, service and other value adds.
Marc Haemel, Managing Director for Rexam Healthcare, commented:
"We are truly honored to be distinguished by Lilly, one of the leading pharmaceutical companies in the world.
We have demonstrated our capacity to manage a large scale industrial project in close partnership with Lilly and to create value with high-quality solutions and support services, for the entire benefit of diabetic patients throughout the world.
We are proud of our teams for this achievement and will strive to improve further the value we bring to Lilly.”
Marc Haemel, Managing Director for Rexam Healthcare, commented:
"We are truly honored to be distinguished by Lilly, one of the leading pharmaceutical companies in the world.
We have demonstrated our capacity to manage a large scale industrial project in close partnership with Lilly and to create value with high-quality solutions and support services, for the entire benefit of diabetic patients throughout the world.
We are proud of our teams for this achievement and will strive to improve further the value we bring to Lilly.”
Companies in this article
![“Another key [UDI] benefit, because we're calling that product by the same name across the healthcare supply chain… rich and robust data that we can access around supply consumption and utilization rates. One of the buzz terms we've heard during the COVID-19 crisis was what's my burn rate? How fast am I going through gowns, masks, gloves?” – Mike Schiller, Senior Director at AHRMM](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2020/08/UDI.5f4d326e41d53.png?auto=format&fit=crop&h=146&w=340)
